Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury-Reference-Cited by-同舟云学术

Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury

Published:2010-02 Issue:3 Volume:112 Page:807-817
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

PifarrÃ© Paula,Prado Judith,Giralt Mercedes,Molinero Amalia,Hidalgo Juan,Garcia Agustina

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2009.06518.x/fullpdf

Reference53 articles.

1. Ca2+/calmodulin-dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from rat cerebellum;Agullo;Eur. J. Pharmacol.,1997

2. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells;Baltrons;J. Neurochem.,1999

3. Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells;Baltrons;Neurobiol. Dis.,2002

4. Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains;Baltrons;Neurobiol. Dis.,2004

5. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol. Rev.,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-vivo and In-vitro Investigations to Assess Traumatic Brain Injury;CNS & Neurological Disorders - Drug Targets;2024-02

2. Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury;Neurotherapeutics;2023-10

3. cGMP Signaling in the Neurovascular Unit—Implications for Retinal Ganglion Cell Survival in Glaucoma;Biomolecules;2022-11-11

4. The Interplay between cGMP and Calcium Signaling in Alzheimer’s Disease;International Journal of Molecular Sciences;2022-06-24

5. A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis;Neurology and Therapy;2022-05-24